Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitelaw, A.
Right arrow Articles by Thoresen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitelaw, A.
Right arrow Articles by Thoresen, M.
Related Collections
Right arrow Drugs: central nervous system (not psychiatric)
Right arrow Drugs: obstetrics and gynecology
Right arrow Perinatal
Arch Dis Child Fetal Neonatal Ed 2000;83:F154-F157 ( September )

Current topic

Antenatal steroids and the developing brain Andrew Whitelawa, Marianne Thoresenb

a Division of Child Health, University of Bristol Medical School, Southmead Hospital, Bristol BS10 5NB, UK, b Division of Child Health, St Michael's Hospital, Bristol BS2 8EG, UK

Correspondence to: Professor Whitelaw email: andrew.whitelaw{at}bristol.ac.uk

Accepted 5 June 2000

Randomised clinical trials show that two injections of corticosteroid into the mother before preterm delivery reduce respiratory distress syndrome, neonatal mortality, and intraventricular haemorrhage. However, repeated courses of antenatal steroid are not backed by such evidence of safety and efficacy. Animal studies have shown that maternal corticosteroid delays myelination and reduces the growth of all fetal brain areas particularly the hippocampus. Corticosteroids may reduce or enhance hypoxic-ischaemic injury to the developing brain depending on timing and dosage. Clinical trials of maternally administered corticosteroid show no evidence of increased disability on follow up but numbers are small. Postnatal trials of dexamethasone when brain maturity is still preterm show a significant increase in later disability in the dexamethasone treated groups. There is evidence from randomised trials, retrospective data, experiments on pregnant mice, and the chemical make up of the preparations that betamethasone may be safer and more protective of the immature brain than dexamethasone. Single course corticosteroid treatment before preterm delivery must still be recommended as a life saving and cost effective intervention, but clinicians may wish to change from using dexamethasone to betamethasone. In view of the animal and postnatal data, clinicians should be cautious with repeated courses of antenatal corticosteroids and repetition may be unnecessary for lung maturity.


© 2000 by Archives of Disease in Childhood



This article has been cited by other articles:


Home page
Anesth. Analg.Home page
V. Degos, G. Loron, J. Mantz, and P. Gressens
Neuroprotective Strategies for the Neonatal Brain
Anesth. Analg., June 1, 2008; 106(6): 1670 - 1680.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
M Vural, I Yilmaz, F Oztunc, B Ilikkan, E Erginoz, and Y Perk
Cardiac effects of a single course of antenatal betamethasone in preterm infants
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2006; 91(2): F118 - F122.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. R. Neal Jr., G. Weidemann, M. Kabbaj, and D. M. Vazquez
Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R375 - R385.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
P V Mohan, W Tarnow-Mordi, B Stenson, P Brocklehurst, K Haque, V Cavendish, and A Cust
Can polyclonal intravenous immunoglobulin limit cytokine mediated cerebral damage and chronic lung disease in preterm infants?
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2004; 89(1): F5 - F8.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. B. Flagel, D. M. Vazquez, S. J. Watson Jr., and C. R. Neal Jr.
Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R55 - R63.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
B. S. Peterson and L. R. Ment
The Necessity and Difficulty of Conducting Magnetic Resonance Imaging Studies on Infant Brain Development
Pediatrics, March 1, 2001; 107(3): 593 - 594.
[Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Ahlbom, V. Gogvadze, M. Chen, G. Celsi, and S. Ceccatelli
Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death
PNAS, December 8, 2000; (2000) 260501697.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Ahlbom, V. Gogvadze, M. Chen, G. Celsi, and S. Ceccatelli
Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death
PNAS, December 19, 2000; 97(26): 14726 - 14730.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

Single versus multiple courses of antenatal steroids - uncertainty remains
Simon Gates
Fetal Neonatal Ed. Online, 22 Nov 2000 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health